Collegium Pharmaceutical Inc (COLL)
37.51
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
37.53
+0.02
(+0.05%)
Pre-Market: 20:00
Collegium Pharmaceutical 1 Year Total Returns (Daily): 69.65% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | 69.65% |
May 02, 2024 | 68.21% |
May 01, 2024 | 64.33% |
April 30, 2024 | 58.70% |
April 29, 2024 | 57.76% |
April 26, 2024 | 59.46% |
April 25, 2024 | 57.33% |
April 24, 2024 | 51.62% |
April 23, 2024 | 55.79% |
April 22, 2024 | 50.59% |
April 19, 2024 | 52.27% |
April 18, 2024 | 50.26% |
April 17, 2024 | 53.00% |
April 16, 2024 | 54.38% |
April 15, 2024 | 53.25% |
April 12, 2024 | 61.73% |
April 11, 2024 | 54.52% |
April 10, 2024 | 60.50% |
April 09, 2024 | 65.13% |
April 08, 2024 | 67.82% |
April 05, 2024 | 70.17% |
April 04, 2024 | 63.75% |
April 03, 2024 | 66.53% |
April 02, 2024 | 60.07% |
April 01, 2024 | 62.07% |
Date | Value |
---|---|
March 28, 2024 | 60.61% |
March 27, 2024 | 69.40% |
March 26, 2024 | 67.98% |
March 25, 2024 | 68.95% |
March 22, 2024 | 65.09% |
March 21, 2024 | 59.34% |
March 20, 2024 | 61.29% |
March 19, 2024 | 59.03% |
March 18, 2024 | 64.85% |
March 15, 2024 | 65.29% |
March 14, 2024 | 56.12% |
March 13, 2024 | 59.92% |
March 12, 2024 | 53.34% |
March 11, 2024 | 53.75% |
March 08, 2024 | 45.85% |
March 07, 2024 | 43.30% |
March 06, 2024 | 44.47% |
March 05, 2024 | 34.78% |
March 04, 2024 | 37.45% |
March 01, 2024 | 38.60% |
February 29, 2024 | 38.37% |
February 28, 2024 | 37.84% |
February 27, 2024 | 37.28% |
February 26, 2024 | 36.16% |
February 23, 2024 | 36.65% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-57.84%
Minimum
Jun 17 2019
102.6%
Maximum
Oct 01 2020
13.93%
Average
15.95%
Median
Apr 23 2021
1 Year Total Returns (Daily) Benchmarks
Catalyst Pharmaceuticals Inc | -11.33% |
Immunogen Inc (DELISTED) | -- |
AnaptysBio Inc | 23.63% |
Recursion Pharmaceuticals Inc | 71.32% |
Nuvalent Inc | 89.42% |